Patient-Centric, Point-of-Need Eye Assessments that Accelerate Clinical Trials
From an unusual beginning along an unexpected path, 20/20 Onsite has become a leading healthcare services company providing essential eye assessments and other eye-related services that are transforming how clinical trials, research, and therapy delivery are conducted.
Our Beginning
In 2014, frustrated by the hassle and inconvenience of getting an eye exam, Howard Bornstein founded 20/20 Onsite to deliver high-quality eye care directly to the point of need. Initially serving large employers, 20/20 Onsite developed a fleet of state-of-the-art clinics that operated at or near where patients live, work, or go to school. By Spring of 2020, we were serving hundreds of corporations and tens of thousands of patients in three major markets. Then the pandemic hit.
Shift Towards Clinical Research
While the pandemic caused offices nationwide to close their doors, shuttering our corporate business, it also disrupted a critical clinical trial sponsored by a major pharmaceutical company. Trial participants were reluctant to visit existing trial sites, potentially compromising trial protocols, data, timelines, and budget! Engaged by the Sponsor to deploy our point-of-need service platform reaching trial participants at locations convenient to them, even their driveways, 20/20 Onsite helped the Sponsor put the trial back on track for a successful, timely completion.
This experience led us to reevaluate our business model and focus on becoming a leading clinical trial solutions provider for eye-related requirements—a natural fit for our expertise. With hundreds of clinical trials in progress at any given moment, and many more planned, the demand for eye assessments that we have delivered thousands of times continues to grow.
Since 2020, we have expanded our services to meet the growing demand for clinical research, supporting Phase 1-4 trials and post-marketing activities for both ophthalmic and non-ophthalmic indications. We have built our reputation on trial-specific eye assessments through our three innovative delivery modalities, including:
- Mobile Vision Clinics: Specially-equipped, fully-staffed vehicles providing comprehensive, certified eye assessments essentially anywhere, eliminating geographical barriers.
- On-site Pods: Semi-permanent, modular examination spaces that can be easily set up and customized for specific study requirements, enhancing convenience and accessibility.
- On-site Clinic Suites: Portable, ‘pop up’ solutions that bring ophthalmic equipment and certified staff to existing exam rooms and suitable facilities, seamlessly integrating with clinic workflows.
How We Make a Difference in Clinical Research
Our flexible solutions, backed by decades of experience, seamlessly integrate into clinical trial activities. We act as a partner for Sponsors in realizing valuable benefits for their clinical trials, including:
- Higher likelihood of on-time, on-budget trial completion
- Enhanced trial data consistency and quality resulting in fewer queries
- Ability to recruit and serve in from hard-to-reach or otherwise under-served trial participant populations and geographies
- Improved retention of engaged participants
With an average Net Promoter Score of 97, our patients consistently report high satisfaction with the care they receive, and our 98% data submission accuracy ensures the highest standards in clinical trial support.
A Vision for the Future
We are committed to pushing the boundaries of healthcare accessibility. We are proud to be the trusted partner of leading pharmaceutical companies, CROs, and clinical research sites across the United States. Increasingly, we play a key role in drug therapy development, chronic disease management, and clinical research. We are more than just a healthcare service provider—we are a highly experienced partner committed to improving the lives of patients and advancing the future of clinical research.
Our Mission: Go the extra mile to make high-quality vision care more accessible, creating healthier and happier communities.
